HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

First bite syndrome following transcervical arterial ligation after transoral robotic surgery.

AbstractOBJECTIVE:
To assess the incidence of first bite syndrome (FBS) in transoral robotic surgical (TORS) patients undergoing transcervical arterial ligation.
METHODS:
Retrospective case series of all patients diagnosed with FBS following prophylactic transcervical arterial ligation of branches of the external carotid system between March 2010 and December 2016 at a single academic center.
RESULTS:
Six patients with FBS after TORS with transcervical arterial ligation were evaluated, representing 7% of all patients who underwent neck dissection with concomitant transcervical arterial ligation (6 of 83). Median presentation of FBS was 63 days, with an average duration of 66 days. Treatment ranged from observation to botulinum toxin injection.
CONCLUSION:
Patients who undergo transcervical arterial ligation to minimize bleeding complications following TORS are at risk of developing first bite syndrome.
LEVEL OF EVIDENCE:
4. Laryngoscope, 128:1589-1593, 2018.
AuthorsMichael C Topf, Ethan Moritz, John Gleysteen, Joseph M Curry, David M Cognetti, Adam J Luginbuhl
JournalThe Laryngoscope (Laryngoscope) Vol. 128 Issue 7 Pg. 1589-1593 (Jul 2018) ISSN: 1531-4995 [Electronic] United States
PMID29152739 (Publication Type: Journal Article)
Copyright© 2017 The American Laryngological, Rhinological and Otological Society, Inc.
Topics
  • Adult
  • Aged
  • Carotid Artery, External (surgery)
  • Facial Pain (etiology)
  • Humans
  • Ligation
  • Male
  • Mastication
  • Middle Aged
  • Neck (blood supply)
  • Neck Dissection (methods)
  • Oropharyngeal Neoplasms (surgery)
  • Otorhinolaryngologic Surgical Procedures (adverse effects)
  • Parotid Gland (innervation)
  • Postoperative Complications
  • Postoperative Hemorrhage (prevention & control)
  • Retrospective Studies
  • Robotic Surgical Procedures (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: